Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Lung Cancer (Amsterdam, Netherlands)|February 27, 1999
Gemcitabine in locally advanced and metastatic non-small cell lung cancer: the Central European phase II studyP Zatloukal, E Kanitz, P Magyar, et al.
Lung Cancer (Amsterdam, Netherlands)|March 4, 2000
A multicenter, randomized, phase III study of docetaxel plus best supportive care versus best supportive care in chemotherapy-naive patients with metastatic or non-resectable localized non-small cell lung cancer (NSCLC)K Roszkowski, A Pluzanska, M Krzakowski, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 5, 2002
A multicenter randomized phase II study of oral vs. intravenous vinorelbine in advanced non-small-cell lung cancer patientsJ Jassem, R Ramlau, H Karnicka-Młodkowska, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 14, 2003
Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors: a phase III, double-blind, randomized trial--the Zoledronic Acid Lung Cancer and Other Solid Tumors Study GroupLee S Rosen, David Gordon, Simon Tchekmedyian, et al.
Clinical Lung Cancer|August 30, 2024
Outcomes Analysis of Patients Receiving Local Ablative Therapy for Oligoprogressive Metastatic NSCLC Under First-Line ImmunotherapyC Huet, C Basse, M Knetki-Wroblewska, et al.
European Review for Medical and Pharmacological Sciences|May 23, 2019
Diagnostic value of plasma expression of microRNAs complementary to Drosha and Dicer in lung cancer patientsM Szczyrek, B Kuźnar-Kamińska, A Grenda, et al.
Lung Cancer (Amsterdam, Netherlands)|April 14, 2012
Prognostic factors in patients with advanced non-small cell lung cancer: data from the phase III FLEX studyR Pirker, J R Pereira, A Szczesna, et al.
European Journal of Cancer (Oxford, England : 1990)|June 27, 2003
Carboplatin and paclitaxol (Taxol) as an induction regimen for patients with biopsy-proven stage IIIA N2 non-small cell lung cancer. an EORTC phase II study (EORTC 08958)M E R O'Brien, T Splinter, E F Smit, et al.
Lung Cancer (Amsterdam, Netherlands)|July 19, 2005
Randomized study of vinorelbine--gemcitabine versus vinorelbine--carboplatin in patients with advanced non-small cell lung cancerE H Tan, A Szczesna, M Krzakowski, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 6, 2011
A phase III randomized study of gemcitabine and cisplatin with or without PF-3512676 (TLR9 agonist) as first-line treatment of advanced non-small-cell lung cancerC Manegold, N van Zandwijk, A Szczesna, et al.
Pageof 3